ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,767.57
1.76%
US Tech 100
19,613.20
1.97%
Dow Jones
42,583.32
1.42%
Brent Oil
72.515
-0.02%
Bitcoin
86,856.95
-0.75%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Novo Nordisk (NVO)

  7. Novo Nordisk (NVO) News

NVO

Novo Nordisk (NVO)

Novo Nordisk
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NVO
DateTimeSourceHeadlineSymbolCompany
03/24/20258:00AMPR Newswire (US)Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offerNYSE:NVONovo Nordisk
03/24/20255:45AMPR Newswire (US)The Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming DeadlineNYSE:NVONovo Nordisk
03/20/20255:04AMPR Newswire (US)Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNYSE:NVONovo Nordisk
03/17/20255:45AMPR Newswire (US)Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law FirmNYSE:NVONovo Nordisk
03/13/20255:45AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Nordisk A/S Lawsuit - NVONYSE:NVONovo Nordisk
03/10/20257:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
03/10/20255:45AMPR Newswire (US)NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming DeadlineNYSE:NVONovo Nordisk
03/06/20255:45AMPR Newswire (US)The Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming DeadlineNYSE:NVONovo Nordisk
03/05/20258:00AMPR Newswire (US)Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patientsNYSE:NVONovo Nordisk
03/03/20255:45AMPR Newswire (US)Shareholders that lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVONYSE:NVONovo Nordisk
02/27/202510:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
02/27/20255:45AMPR Newswire (US)Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVONYSE:NVONovo Nordisk
02/24/20255:45AMPR Newswire (US)Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law FirmNYSE:NVONovo Nordisk
02/20/20255:45AMPR Newswire (US)Novo Nordisk A/S Sued for Securities Law Violations - Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVONYSE:NVONovo Nordisk
02/13/20255:45AMPR Newswire (US)Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVONYSE:NVONovo Nordisk
02/10/20255:45AMPR Newswire (US)The Gross Law Firm Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - NVONYSE:NVONovo Nordisk
02/06/20257:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
02/06/20255:45AMPR Newswire (US)The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - NVONYSE:NVONovo Nordisk
02/03/20255:45AMPR Newswire (US)March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVONYSE:NVONovo Nordisk
01/30/20255:45AMPR Newswire (US)NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming DeadlineNYSE:NVONovo Nordisk
01/27/20259:05AMIH Market NewsTech Stocks May Lead Early Sell-Off On Wall StreetNYSE:NVONovo Nordisk
01/24/20254:44PMIH Market NewsU.S. Stocks Move To The Downside But Post Strong Weekly GainsNYSE:NVONovo Nordisk
12/03/20246:00AMGlobeNewswire Inc.Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo NordiskNYSE:NVONovo Nordisk
11/25/202411:17AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
11/19/20249:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
11/18/202411:19AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
11/08/20245:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
11/08/20244:53PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
11/08/20244:50PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
11/06/20246:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NVONovo Nordisk
 Showing the most relevant articles for your search:NYSE:NVO

Your Recent History

AMEX
MIDU
Direxion Daily Mid Cap B...
COIN
OTWOUST
OTWO
TG
5ER
Origin Materials
COIN
ADXUSD
Ambire AdEx
BIT
UC3UPV
Unicredit Bank
AMEX
TSMY
Yieldmax TSM Option Inco...
AMEX
SOXL
Direxion Daily Semicondu...
NYSE
SNOW
Snowflake
NASDAQ
TXN
Texas Instruments
BIT
UC5R40
Unicredit Bank
COIN
XRPHUST
XRP Healthcare
NASDAQ
AUR
Aurora Innovations
NASDAQ
CNTA
Centessa Pharmaceuticals
LSE
44FZ
Assa 25
BIT
P1TL63
BNP Paribas Issuance
TG
2I3
Champions Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads